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Abstract
Past few years cranberry/lingonberry products have been incorporated as healthy products to the
US and European market as prophylaxis of recurrent urinary tract infections in young women as
well as in chronic infections in elderly which because of there are many biological activities
attributed to the that fruit is a very popular additive to the new diets. To the best of our knowledge,
this is the first case of allergy to lingonberry. We speculate that previous exposure to lingonberry
products could be sensitising. The symptoms, timing of the episode, positive skin test, IgE-ELISA
and western-blot strongly support the role of lingonberry as the causative agent.
Background
Lingonberry (Vaccinium vitis-idaea L.), small cranberry
(Vaccinium microcarpum) and bigger cranberry (Vaccinium
oxycoccos L.,) are popular berries in Nordic countries and
Russia, which are used in gravies, dressing and pantry
products. Furthermore, past few years cranberry/lin-
gonberry products have been increasedly marketed as a
natural solution to avoid recurrent urinary infections [1-
4]. Cranberry/lingonberry juice or cranberry-concentrate
tablets, which appear to inhibit the attachment of patho-
gens to uroepithelium [5,6], have been incorporated to
the prophylaxis of chronic urinary tract infections in eld-
erly as well as the prophylaxis of recurrent acute uncom-
plicated urinary tract infection in sexually active
women[2,7].
Case presentation
We herein describe a case of allergy to lingonberry in a 25-
year-old woman with a history of mite allergic rhinitis,
but no food allergies. She entered a restaurant and then
ate meatballs, baked potatoes and lingonberry jam. Dur-
ing the meal, itching wheals developed around her
mouth. Symptoms were solved without treatment. The
patient was not under any treatment on that time. Skin
prick testing by prick-prick method with fresh lingonberry
revealed mean wheal diameter of 5 mm and mean flare
diameter of 20 mm (Figure 1a). Skin tests either with the
foodstuffs involved in the episode or other berries showed
no reaction. On her responsibility and against medical
advice, she subsequently took a very little amount of lin-
gonberry jam several days later. She immediately noticed
more intense symptoms with intense itching on mouth,
tongue and throat and wheals over her mouth. Symptoms
were solved in an hour without treatment.
Methods
We prepared a protein extract of 0.6 mg/ml in phosphate
buffered saline using frozen lingonberries in the presence
of protease inhibitors. After informed consent patient's
serum was obtained. Two independent lingonberry
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allergen extract-coated IgE ELISAs using goat anti-human
IgE-labelled-peroxidase (Sigma-Aldrich, ST Louis, MO,
USA) showed positive results. (OD 495): 0.343 (patient)
vs 0.017 (control) (Mean values from 2 different assays).
SDS-PAGE[8] was performed with a 12% polyacrylamide
gel and a stacking gel of 4%. It was applied 19.2 µg of lin-
gonberry extract to every lane and electrophoresis was per-
formed (Mini Protean II System, Bio-Rad laboratories,
Richmond, USA). Then, proteins were electrophoretically
transferred from the separating gel to Immobilon-P™
(PVDF, Millipore Corporation, Billerica, MA, USA) mem-
branes in a transfer buffer. After blocking with a solution
of gelatine 3% for 1 hour, the membranes were washed
and incubated overnight with patient's and normal con-
trol sera. Next day, membranes were washed and incu-
bated with goat anti-human IgE-labelled-peroxidase as
mentioned above. Detection was performed with a chemi-
luminescence substrate (Pierce Chemical Company,
Rockford, Illinois). The western-blot revealed IgE in the
patient's serum that bound to some medium/high-molec-
ular-weight protein bands (Figure 1b). Control sera were
negative.
Discussion
Lingonberry's native home is in the woods of Norway,
Sweden and Finland. The Nordic countries' people pick
and use about 50 million kg of lingonberries per year[9],
which they use in jams, jellies, preserves, concentrates,
and liquors; the berries are also sold fresh. Interest of lin-
gonberry in the possible health benefits is not only due to
the inhibition of the attachment of pathogens to uroepi-
thelium[5], but also to the total content of flavonoids,
which is higher than that in the commonly consumed
Left. Skin prick test with a positive response to lingonberry fruit Right: Immunoblotting of lingonberry extract. Figure 1
Left. Skin prick test with a positive response to lingonberry fruit Right: Immunoblotting of lingonberry extract. Autoradio-
graph of specific IgE immunoblot of the control (Lane 1) and the patient (Lane 2).
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fruits or vegetables. Some flavonoids, such as querce-
tin[10], in which lingonberries are an excellent source,
have potent antioxidant and free-radical scavenging activ-
ities observed in vitro. Some studies support a protective
effect of flavonoid consumption in cardiovascular disease
and cancer. Because there are many biological activities
attributed to the flavonoids further studies in both the
laboratory and clinic are running.
To the best of our knowledge, this is the first case reported
of allergy to lingonberry. It is tempting to speculate that
previous exposure by means of lingonberry products was
sensitizing. The positive skin test, IgE-ELISA, western-blot
and the symptoms and timing of the episode strongly
implicate lingonberry. This report indicates that the lin-
gonberry products might be allergenic when ingested. Fur-
ther studies would be needed to characterize the allergenic
component or components in lingonberry.
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